1 Min Read
March 22 (Reuters) - ARGENX NV:
* ANNOUNCES EXPANSION OF ITS PIPELINE WITH ADDITION OF COMPLEMENT-TARGETED ARGX-117 FOR TREATMENT OF SEVERE AUTOIMMUNE DISEASES Source text for Eikon: Further company coverage: (Gdynia Newsroom:)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.